...Matt DellaMaria, SVP, IR and Communications, will be retiring at year-end. 1. a. Replacing Matt DellaMaria is Mary Skafidas, who joined just little over a month ago. B. Performance: Strong qtr. 1. 2. All segments contributed positively to topline growth for 2Q22 and 1H22. 3. Growth achieved by increased volumes and pricing initiatives. Achieved this solid performance during exceptionally dynamic and uncertain period. a. 4. Well-positioned for continued growth. 5. Areas of business that were negatively impacted b pandemic, like prescription drug, consumer healthcare, and beauty solutions, are now recovering. 6. Investing in capacity in Pharma and Beauty segments, following regional manufacturing strategy that will allow Co. to grow with customers as they also benefit from life returning to new normal. 7. Pharma: Double-digit core sales growth, with increased volumes across all major healthcare markets. a. b. Prescription business worked through 2021 destocking situation and is ramping up...
